Remisyonda Hodgkin Lenfoma Tanılı Bir CMV Enteriti Olgusu

Year 2017, Volume: 14 Issue: 1, 71 - 74, 28.04.2017

Mehmet Çelik Ali İrfan Baran Betül Ersöz Acar Ömer Kurt Mustafa Asım Karahocagil

Abstract

CMV enterokoliti özellikle immunsupresif hastalarda görülen nadir bir hastalıktır. CMV
enfeksiyonları normal immuniteli kişilerde asemptomatik veya nonspesifik semptomlarla seyreder. Ama
immunsuprese kişilerde önemli morbidite ve mortaliteden sorumlu olabilir (3). CMV enterokoliti genelde
ileumda ve sağ kolonda ortaya çıkar. Kolonoskoide multiple mukozal ülserler görülür. Bu makalede
Remisyonda Hodgkin Lenfoma tanılı bir CMV enteriti olgusu sunuldu.

Keywords

Sitomegalovirüs, Enterokolit, Hodgkin Lenfoma

A CMV enteritis case who has Hodgkin's Lymphoma in remission

Abstract

CMV enterocolitis is a rare disease, especially seen in immunosuppressive patients. CMV
infections are asymptomatic or present with nonspecific symptoms in people with normal immunity. But it
may be responsible for significant morbidity and mortality in immunocompromised persons. CMV
enterocolitis usually occurs in the ileum and right colon. Multıpl mucosal ulcers seen in colonoscopy. In
this article a CMV enteritis case in diagnosed Hodgkin's lymphoma in remission was presented. 

Keywords

cytomegalovirus, enterocolitis, Hodgkin's Lymphoma

References

• 1. Nomura K, Kamıtsuji Y, Kono E, Matsumoto Y, Yoshida N, Konishi H, et al. Severe cytomegalovirus enterocolitis after standard chemotherapy for non-Hodgkin’s lymphoma. Scandinavian Journal of Gastroenterology 2005; 40: 604-606. 2. PageMJ, DreeseJC, Poritz LS, et al. Cytomegalovirus enteritis: A Highly lethal condition requiring early detection and ıntervention. Dis Colon Rectum 1998, Volume 41, Issue 5, p: 619-623. 3. Shinozaki M, Masaki T, Muto T. Cytomegalic colitis after total colectomy in ulcerative colitis: report of a case. Dis Colon Rectum 1997;40:1124-1127. 4. Mayoral JL, Loeffler CM, Fasola CG, Kramer MA, Orrom WJ, et al. Diagnosis and treatment of cytomegalovirus disease in transplant patients based on gastrointestinal tract manifestations. Arch Surg 1991;126:202-206. 5. Shrestha BM, Parton D, Gray A, Shephard D, Griffith D, et al. Cytomegalovirus involving gastrointestinal tract in renal transplant recipients. Clin Transplantation 1996;10:170-175. 6. Schulenburg A, Turetschek K, Wrba F, Vogelsang H, Greinix HT, Keil F, et al. Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation. Ann Hematol 2004;83:101-106. 7. Carpiuc I, Antoun S, Delabarthe A, Driss B, Vantelon JM, Griscelli F, et al. Segmental caecal cytomegalovirus colitis during fludarabine, cytarabine and mitoxantrone induction chemotherapy for myelodysplastic syndrome. Leuk Lymphoma 2002;43:1701-1703. 8. Tezer H, Seçmeer G. Sitomegalovirüs (CMV) infeksiyonları. Hacettepe Tıp Dergisi 2007; 38:1-7. 9. Gümüş HH, Yarkın F. Allojenik Hematopoetik Kök Hücre Transplant Alıcılarında Viral İnfeksiyonların Yönetimi. Arşiv Kaynak Tarama Dergisi 2014; 23(1):118-136. 10. Perrottet N, Csajka C, Pascual M, Manuel O, Lamoth F, Meylan P, et al. Population Pharmacokinetics of Ganciclovir in Solid-Organ Transplant Recipients Receiving Oral Valganciclovir. Antimicrob Agents Chemother 2009 Jul; 53(7): 3017–3023.